IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BUGLIONE DI MONALE E BASTIA, MICHELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.824
AS - Asia 5.808
EU - Europa 5.044
SA - Sud America 1.031
AF - Africa 146
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 24.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.615
SG - Singapore 1.989
CN - Cina 1.941
UA - Ucraina 1.009
BR - Brasile 869
IT - Italia 832
DE - Germania 816
HK - Hong Kong 672
PL - Polonia 613
FI - Finlandia 377
FR - Francia 357
VN - Vietnam 337
GB - Regno Unito 296
RU - Federazione Russa 256
TR - Turchia 235
IE - Irlanda 192
IN - India 164
BD - Bangladesh 163
CA - Canada 105
MX - Messico 60
AR - Argentina 56
ZA - Sudafrica 55
IQ - Iraq 49
SE - Svezia 46
ID - Indonesia 45
CZ - Repubblica Ceca 43
NL - Olanda 41
JP - Giappone 36
EC - Ecuador 33
ES - Italia 32
PK - Pakistan 25
UZ - Uzbekistan 24
CO - Colombia 23
AT - Austria 22
SA - Arabia Saudita 21
VE - Venezuela 21
BE - Belgio 20
NG - Nigeria 19
MA - Marocco 18
AU - Australia 17
LT - Lituania 15
EU - Europa 14
TN - Tunisia 13
GR - Grecia 12
EG - Egitto 10
IR - Iran 10
PA - Panama 10
CL - Cile 9
JO - Giordania 9
PY - Paraguay 9
BY - Bielorussia 8
MY - Malesia 8
NP - Nepal 8
OM - Oman 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
DZ - Algeria 7
IL - Israele 7
JM - Giamaica 7
KE - Kenya 7
SN - Senegal 7
CH - Svizzera 6
HU - Ungheria 6
KG - Kirghizistan 6
AZ - Azerbaigian 5
HN - Honduras 5
PH - Filippine 5
PT - Portogallo 5
TW - Taiwan 5
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
LA - Repubblica Popolare Democratica del Laos 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
KH - Cambogia 3
KR - Corea 3
KW - Kuwait 3
KZ - Kazakistan 3
LV - Lettonia 3
MU - Mauritius 3
NO - Norvegia 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
UY - Uruguay 3
AM - Armenia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
IS - Islanda 2
LB - Libano 2
SL - Sierra Leone 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 24.868
Salva come PNG Salva come JPEG
Città #
Fairfield 1.304
Ashburn 1.298
Woodbridge 1.085
Singapore 1.075
Jacksonville 729
Houston 699
Hong Kong 667
Warsaw 602
Seattle 574
Cambridge 540
Chandler 536
San Jose 516
Ann Arbor 495
Wilmington 473
Beijing 425
The Dalles 385
New York 359
Princeton 337
Los Angeles 247
Helsinki 220
Nanjing 212
Dublin 191
Dearborn 178
Istanbul 176
Lauterbourg 175
Munich 146
Dallas 145
Brescia 112
Milan 104
Buffalo 97
Ho Chi Minh City 94
Shanghai 92
Nanchang 91
São Paulo 91
Des Moines 89
San Francisco 87
Moscow 84
Council Bluffs 77
San Diego 72
Changsha 64
Orem 58
Chicago 55
Santa Clara 54
Dong Ket 52
Hanoi 52
Shenyang 51
Jinan 50
Hebei 49
London 48
Tianjin 48
Turku 47
Washington 47
Redondo Beach 46
Boardman 42
Jiaxing 37
Montreal 36
Denver 35
Chennai 34
Kunming 34
Nuremberg 33
Hangzhou 31
Johannesburg 31
Tokyo 31
Brooklyn 30
Toronto 30
Jakarta 28
Poplar 28
Frankfurt am Main 27
Rio de Janeiro 27
Brno 26
Lancaster 25
Zhengzhou 25
Manchester 24
Mexico City 23
Rome 23
Tashkent 22
Ningbo 21
Phoenix 21
Brussels 20
Atlanta 19
Brasília 19
Abuja 18
Amsterdam 18
Kocaeli 18
Stockholm 18
Boston 17
Da Nang 17
Guangzhou 17
Ceto 16
Dhaka 16
Haikou 16
Mumbai 16
Quito 16
Taizhou 16
Ankara 15
Curitiba 15
Lanzhou 15
Nürnberg 15
Verona 15
Baronissi 14
Totale 16.690
Salva come PNG Salva come JPEG
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 280
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 269
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 266
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 251
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 249
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 227
Pros-IT CNR: an Italian prostate cancer monitoring project 224
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 222
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 220
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 212
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 210
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 209
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 199
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 199
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 194
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 192
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 191
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 189
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 188
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 185
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 183
Radiotherapy in patients with HIV: current issues and review of the literature 182
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 181
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 180
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 178
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 177
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 176
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 176
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 175
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 174
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 174
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 174
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 173
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 171
Role of external beam radiotherapy in the treatment of relapsing meningioma 171
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 170
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 169
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 168
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 166
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 166
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 165
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 165
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 165
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 163
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 162
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 162
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 162
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 160
From Molecular to Clinical Radiation Biology of Glioblastoma 159
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 158
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 158
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 158
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 157
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 157
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 157
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 156
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 156
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 155
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 155
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 154
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 153
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 153
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 152
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 151
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 151
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 150
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 147
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 147
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 146
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 145
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 144
Cetuximab and Radiation Therapy in Head and Neck Cancer 143
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 142
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 142
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 140
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 140
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 140
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 140
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 139
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 139
Information Retrieval in Medicine: an Extensive Experimental Study 137
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 136
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 135
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 135
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 133
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 133
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 133
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 133
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 133
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 133
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 132
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 132
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 128
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 128
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 127
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 127
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 127
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 125
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 125
Totale 16.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021195 0 0 0 0 0 0 0 0 0 0 0 195
2021/20221.355 110 197 38 58 16 75 54 113 75 161 86 372
2022/20231.362 188 88 47 103 126 339 6 138 214 17 53 43
2023/20241.813 87 32 192 94 97 413 64 80 350 53 79 272
2024/20253.375 31 41 29 491 333 300 285 139 317 286 725 398
2025/20267.163 680 915 493 936 762 487 1.048 246 473 603 369 151
Totale 25.299